Assenagon Asset Management Trims DaVita Stake

Investment firm reduces holdings in dialysis provider by over a third

Mar. 29, 2026 at 7:20am

Got story updates? Submit your updates here. ›

Assenagon Asset Management S.A. decreased its position in shares of DaVita Inc. (NYSE:DVA) by 37.7% during the fourth quarter, according to a recent SEC filing. The firm owned 42,628 shares of the company's stock after selling 25,780 shares during the period.

Why it matters

This move by a major institutional investor signals a shift in sentiment around DaVita, one of the largest dialysis providers in the U.S. The reduction in Assenagon's stake could indicate broader concerns about the company's future performance or the overall outlook for the dialysis industry.

The details

Assenagon Asset Management S.A. sold off a significant portion of its DaVita holdings in the fourth quarter, reducing its stake by 37.7%. The firm now owns 42,628 shares of the dialysis company, down from 68,408 shares held previously.

  • Assenagon reduced its DaVita holdings during the fourth quarter of 2025.

The players

Assenagon Asset Management S.A.

A European investment management firm that has reduced its stake in dialysis provider DaVita Inc.

DaVita Inc.

A leading provider of kidney care services, specializing in the management and operation of outpatient dialysis centers.

Got photos? Submit your photos here. ›

The takeaway

This move by a major institutional investor like Assenagon could signal broader concerns about the dialysis industry and DaVita's future performance. It will be important to monitor if other large investors follow suit and reduce their exposure to DaVita in the coming quarters.